4//SEC Filing
Friedman Ashley 4
Accession 0001192482-19-000421
CIK 0001561921other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:48 PM ET
Size
20.4 KB
Accession
0001192482-19-000421
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Friedman Ashley
Director
Transactions
- Conversion
Warrant (right to buy)
2019-11-13+31,168→ 31,168 total(indirect: By Partnership)Exercise: $28.65From: 2019-11-13Exp: 2027-01-18→ Common Stock (1,262 underlying) - Conversion
Warrant (right to buy)
2019-11-13+148,499→ 148,499 total(indirect: By Partnership)Exercise: $28.65From: 2019-11-13Exp: 2027-01-18→ Common Stock (6,014 underlying) - Conversion
Series B Preferred Stock
2019-11-13−7,051,009→ 0 total(indirect: By Partnership)→ Common Stock (285,580 underlying) - Conversion
Common Stock
2019-11-13+59,940→ 106,052 total(indirect: By Partnership) - Conversion
Common Stock
2019-11-13+285,580→ 505,281 total(indirect: By Partnership) - Conversion
Warrant (right to buy)
2019-11-13−31,168→ 0 total(indirect: By Partnership)Exercise: $1.16From: 2017-01-18Exp: 2027-01-18→ Series B Preferred Stock (31,168 underlying) - Conversion
Series B Preferred Stock
2019-11-13−1,479,951→ 0 total(indirect: By Partnership)→ Common Stock (59,940 underlying) - Conversion
Warrant (right to buy)
2019-11-13−148,499→ 0 total(indirect: By Partnership)Exercise: $1.16From: 2017-01-18Exp: 2027-01-18→ Series B Preferred Stock (148,499 underlying)
Footnotes (5)
- [F1]Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Reflects 46,112 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- [F3]Reflects 219,701 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- [F4]Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
- [F5]Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
TELA Bio, Inc.
CIK 0001561921
Entity typeother
Related Parties
1- filerCIK 0001790193
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 8:48 PM ET
- Size
- 20.4 KB